Copyright © Inderes 2011 - present. All rights reserved.
Log in to receive notifications.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial calendar
    • Research
    • Articles
    • Insider transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Learn
    • Investing School
    • Q&A
    • Analysis school
  • About us
    • Our coverage
    • Team
Log in to your Inderes Free account to see all free content on this page.
Create account

Optomed

3.895

 

EUR

 

-2.5 %

5,447 following

OPTOMED

NASDAQ Helsinki

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Compare
-2.5%
-9.21%
-16.42%
-8.78%
-25.81%
+8.34%
-28.4%
-18.85%
-14.96%

Optomed is a medical technology company. The company conducts research and development of specialized eye cameras. Development takes place of both hardware and software that is resold under different brands. The company operates worldwide, with the largest presence in the Nordic market. The customers consist of research institutes and hospitals. Optomed is headquartered in Oulu.

Read more
Market cap
76.71M EUR
Turnover
167.78K EUR
P/E (adj.) (25e)
EV/EBIT (adj.) (25e)
P/B (25e)
EV/S (25e)
Dividend yield-% (25e)
Coverage
Recommendation
Accumulate
Target price
Updated
14.02.2025
Disclaimer
Juha Kinnunen
Juha Kinnunen

Analyst

Revenue and EBIT-%
27.527.518.418.49.29.200-34.8-24.3-39.6-27.1-11.01.122222323242425e25e26e26e27e27e

Revenue M

EBIT-% (adj.)

EPS and dividend
00-0.2-0.2-0.4-0.422222323242425e25e26e26e27e27e

EPS (adj.)

Dividend %

Financial calendar
6.5.
2025

Interim report Q1'25

7.8.
2025

Interim report Q2'25

6.11.
2025

Interim report Q3'25

Risk
Business risk
Valuation risk
Low
High
ShowingAll content types
Regulatory press release2/27/2025, 7:00 AM

Optomed Oyj: Optomed Annual Report 2024 published

Optomed
Press release2/14/2025, 8:48 AM

Redeye: Optomed Q4 - Quarter in line with expectations

Optomed
Regulatory press release2/13/2025, 7:00 AM

Optomed Oyj: Optomed Plc: Financial Statements Bulletin, January - December 2024

Optomed

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account
Regulatory press release1/31/2025, 7:00 AM

Optomed Oyj: Proposal of Optomed's Nomination Board

Optomed
Life Science Companies as Investments | Life Science Night Dec. 2, 2024
Video12/2/2024, 2:00 PM

Life Science Companies as Investments | Life Science Night Dec. 2, 2024

Antti Siltanen, Life Science Analyst, PhD, talks about life science companies as investments.

Aiforia TechnologiesBBS-Bioactive Bone SubstitutesBioretecBiohitFaron PharmaceuticalsModulightNexstimOrionBittiumDetection TechnologyOptomedRevenio GroupNightingale HealthHerantis PharmaNanoform Finland
Regulatory press release11/14/2024, 9:00 AM

Optomed Oyj: Disclosure under Chapter 9, Section 10 of the Securities Markets Act regarding change in holdings

Optomed
Regulatory press release11/13/2024, 9:00 AM

Optomed Oyj: Share subscriptions based on stock options 2018C

Optomed
Regulatory press release11/11/2024, 7:00 PM

Optomed Oyj: Inside information, profit warning: Optomed receives a large order in the US and increases its full year outlook

Optomed
Press release11/8/2024, 12:26 PM

Redeye: Optomed Q3 - In line with the expectations

Optomed
Regulatory press release11/7/2024, 7:00 AM

Optomed Oyj: Optomed Plc: Interim Report, January - September 2024

Optomed
Regulatory press release9/30/2024, 5:40 AM

Optomed Oyj: Disclosure under Chapter 9, Section 10 of the Securities Markets Act regarding change in holdings

Optomed
Regulatory press release9/25/2024, 5:00 PM

Optomed Oyj: Inside information, profit warning: Optomed decreases its full year outlook

Optomed
Regulatory press release9/11/2024, 6:00 AM

Optomed Oyj: Composition of Optomed's Nomination Board

Optomed
Regulatory press release8/12/2024, 9:00 AM

Optomed Oyj: Optomed Plc - Managers' transactions - Myllylä

Optomed
Regulatory press release8/9/2024, 3:30 PM

Optomed Oyj: Optomed Plc - Managers' transactions - Calarco

Optomed
Regulatory press release8/9/2024, 3:30 PM

Optomed Oyj: Optomed Plc - Managers' transactions - Piila

Optomed
Regulatory press release8/9/2024, 3:30 PM

Optomed Oyj: Optomed Plc - Managers' transactions - Salonen

Optomed
Regulatory press release8/9/2024, 3:30 PM

Optomed Oyj: Optomed Plc - Managers' transactions - Tenstam

Optomed
Regulatory press release8/9/2024, 3:30 PM

Optomed Oyj: Optomed Plc - Managers' transactions - Mäkinen

Optomed
Regulatory press release8/9/2024, 3:30 PM

Optomed Oyj: Optomed Plc - Managers' transactions - Lee

Optomed
Forum discussions
Siitä sitten vähän iltalukemista Optomedin vuosikertomuksen muodossa. Inderes Optomed Oyj: Optomedin vuosikertomus vuodelta 2024 on julkaistu - Inderes Optomed Oyj Pörssitiedote 27.2.2025, klo 9.00, HelsinkiOptomedin vuosikertomus vuodelta 2024 on julkaistuOptomedin vuosikertomus...
2/27/2025, 7:12 AM
by BossoB
25
Optomedillä on ainakin AI-kumppanit parhaasta päästä, Toku Eyes napsii palkintoja vähän väliä. linkedin.com Ehsan Vaghefi on LinkedIn: Another month, another award for Toku This time,... Another month, another award for Toku This time, we have been chosen as the "Best Use of AI in...
2/28/2025, 7:18 AM
by Sheikki
21
Tästä oli puhetta viime haastattelussa ja Himberg oli melkoisen varma, että ei tulisi vaikuttamaan, sillä kamerat valmistetaan Thaimaassa. En usko, että tullia lätkitään ensimmäisenä tähän segmenttiin. Ei nyt varmasti ihan täysin pystytä näiltä välttymään, kuten Revenion toimari ...
2/26/2025, 6:26 PM
by Jankkeri
17
Optomed Osakkeenomistajat Suurimmat osakkeenomistajat. Ei mitään ihmeellistä tällä rintamalla ole. SEB:in kautta vielä lappua laitettu pois, muuten ei muutoksia kauheasti ole. Vaihto ollut myös hiljasta nyt osarin jälkeen, aika odottavaiset tunnelmat tuntuu olevan.
yesterday
by BossoB
13
“”“”““Tämä uusi laite edustaa merkittävää harppausta eteenpäin kuvantamisen laadussa , käytettävyydessä ja liitettävyydessä , mikä vahvistaa tuotevalikoimaamme ja kilpailuasemaamme markkinoilla. “”””“”" Yllä lainaus vuosikertomuksesta . Tämä uusi kamera Optomed Lumo tulee olemaan...
2/27/2025, 1:32 PM
by j.sälli
13
Tulee ehkä jo H1, niin Himberg on vihjaillut, muttei uskalla varmaksi sanoa. Hehkutus on kovaa, ja se ei taida olla ihan katteetonta.
2/27/2025, 1:50 PM
by Puutaheinää
12
Intia ja EU pyrkivät solmimaan vapaakauppa sopimuksen vuoden loppuun mennessä.Siinä olisi iso markkina USA:n ja Kiinan lisäksi/sijaan, etenkin tuon maan väestön asumisolosuhteet tukisivat hienosti tuon kannettavan kameran käyttöä,tuolla kun isoa osaa väestöä ei varmaan saavuteta ...
2/28/2025, 3:00 PM
by Aldrin
11
Read more on our forum
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial calendar
    • Research
    • Articles
    • Insider transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Learn
    • Investing School
    • Q&A
    • Analysis school
  • About us
    • Our coverage
    • Team

Privacy preferences

Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.